Adenosine A2A receptor mRNA 3' untranslated region (ADORA2A mRNA 3' UTR)

The Adenosine A2A receptor (ADORA2A) mRNA 3' untranslated region (3' UTR) is a critical regulatory segment of the ADORA2A transcript that governs the stability and translation efficiency of the receptor protein. This region contains specific binding sites for various microRNAs (miRNAs), such as the miR-15/16 family and miR-214, which act as post-transcriptional repressors to fine-tune receptor density on the cell surface (PubMed: 22492585). The A2A receptor itself is a G protein-coupled receptor (GPCR) that plays a pivotal role in the tumor microenvironment by mediating adenosine-induced immunosuppression of T-cells and natural killer cells (NIH: PMC6361351). In neurobiology, the 3' UTR-mediated regulation of ADORA2A is linked to the pathophysiology of Parkinson's disease, where altered receptor expression in the striatum influences motor control and dopaminergic signaling (PubMed: 25662275). While traditional therapeutics like Istradefylline target the A2A protein, the mRNA 3' UTR is an emerging target for RNA-based therapies, including antisense oligonucleotides and miRNA mimics, designed to modulate receptor levels at the source. Such strategies aim to enhance anti-tumor immunity or provide neuroprotection by correcting the dysregulated expression patterns observed in chronic diseases.

Other names

ADORA2A 3' UTRAdenosine A2A receptor 3' UTRADORA2A mRNA regulatory regionAdenosine receptor A2A 3' untranslated region

Post-transcriptional gene silencing via miRNA-mediated mRNA degradation or translational repression; modulation of mRNA stability through RNA-binding protein interaction.